Hologic Inc. Files 8-K on Financials

Ticker: HOLX · Form: 8-K · Filed: Feb 5, 2025 · CIK: 859737

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Hologic dropped its 8-K, check the financials!

AI Summary

Hologic, Inc. filed an 8-K on February 5, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details information related to the company's financial performance and includes exhibits for the period ending February 5, 2025. Hologic, Inc. is incorporated in Delaware and its principal executive offices are located in Marlborough, Massachusetts.

Why It Matters

This filing provides investors with crucial updates on Hologic's financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

This 8-K filing pertains to Hologic, Inc.'s 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.

When was this 8-K report filed?

The report was filed on February 5, 2025.

Where are Hologic, Inc.'s principal executive offices located?

Hologic, Inc.'s principal executive offices are located at 250 Campus Drive, Marlborough, Massachusetts 01752.

What is Hologic, Inc.'s state of incorporation?

Hologic, Inc. is incorporated in Delaware.

What is the SIC code for Hologic, Inc.?

The Standard Industrial Classification (SIC) code for Hologic, Inc. is 3844, which corresponds to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.

Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-02-05 16:01:21

Filing Documents

02

Item 2.02 Results of Operations and Financial Condition. On February 5, 2025, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 28, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such a filing. Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated February 5, 2025, of Hologic, Inc. announcing its financial results for the first quarter ended December 28, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 5, 2025 HOLOGIC, INC. By: /s/ Karleen M. Oberton Karleen M. Oberton Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing